BioSpace News Archive

Kintara Therapeutics, Inc. today announced that the U.S. Patent and Trademark Office has issued to Kintara United States Patent No. 11,234,955 covering a method of treating brain tumors.

Intrivo, a U.S.-based health-tech leader, launched the beta version of its On/Go Advanced Care Toolkit (ACT), a one-of-a-kind rapid-testing support solution available for free in the On/Go mobile app exclusively for people who use the company’s On/Go COVID-19 Antigen Self-Test.

Engage Technologies Group, Inc. has announced David Pennington, RN , BSN, MBA as its new Senior Vice President of Engage Ocular.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) will release its fourth-quarter and full-year 2021 financial results on Wednesday, Feb. 23, 2022.

CytoSorbents Corporation announces management will participate in two upcoming virtual investor conferences.

UBC enters into partnership with Seqster for a best-in-class patient engagement platform to provide real-time, real-world connectivity.

ESSA Pharma Inc. today provided a corporate update and reported financial results for the fiscal first quarter ended December 31, 2021.

Researchers from Johns Hopkins University have shown that a new panel of long mononucleotide repeats (LMR) might offer advantages over traditional microsatellite instability (MSI) detection methods in certain types of solid tumors.

Repare Therapeutics Inc., a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, announced that members of its senior management team will participate in two virtual investor conferences in February.

Sierra Oncology, Inc., a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, announced the company will participate in the 4th Annual Guggenheim Oncology Conference being held virtually from February 9 – 11, 2022.